Table 2.
Incidence, deaths and disability-adjusted life years for all cancers and 29 cancer groups in the Eastern Mediterranean Region, both sexes, 2015 (Global Burden of Disease Study 2015, Eastern Mediterranean Region, 2015)
| Cause | Number of incident cases | Number of deaths | Number of DALYs (in thousands) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Males | Females | Both | Males | Females | Both | Males | Females | Both | |
| All cancers groups | 309,240 (282,640–340,657) | 413,406 (361,086–467,300) | 722,646 (660,722–790,102) | 198,164 (181,894–217,561) | 180,929 (160,360–202,560) | 379,093 (350,252–408,580) | 5865 (5354–6474) | 5875 (5191–6608) | 11,740 (10,800–12,742) |
| Lip and oral cavity cancer | 14,068 (10,664–18,701) | 15,358 (11,296–21,357) | 29,426 (23,752–36,473) | 4918 (4009–6069) | 4837 (3841–5943) | 9755 (8315–11,408) | 161 (127–203) | 151 (119–187) | 312 (263–368) |
| Nasopharynx cancer | 3219 (2080–4681) | 1836 (1041–2849) | 5055 (3606–6940) | 1469 (1242–1776) | 825 (680–984) | 2294 (2006–2681) | 52 (43–63) | 30 (25–36) | 82 (71–97) |
| Other pharynx cancer | 4394 (3516–5394) | 3593 (2915–4365) | 7988 (6914–9273) | 1654 (1410–1976) | 1391 (1165–1641) | 3045 (2679–3457) | 46 (40–55) | 40 (34–48) | 87 (76–99) |
| Esophageal cancer | 8795 (7449–10,517) | 7992 (6474–9848) | 16,788 (14,577–19,253) | 9345 (8068–10,879) | 8396 (6823–10,239) | 17,741 (15,743–20,073) | 265 (223–317) | 251 (203–313) | 516 (452–595) |
| Stomach cancer | 27,093 (24,235–30,565) | 17,725 (14,951–20,558) | 44,818 (40,719–49,095) | 17,462 (15,667–19,460) | 11,847 (9954–13,631) | 29,309 (26,728–31,947) | 441 (394–496) | 328 (264–387) | 769 (690–851) |
| Colon and rectum cancer | 18,662 (16,276–21,216) | 17,150 (15,090–19,477) | 35,813 (32,240–39,507) | 13,268 (11,666–14,925) | 13,148 (11,498–14,918) | 26,416 (23,736–29,279) | 392 (335–450) | 373 (321–427) | 764 (678–859) |
| Liver cancer | 14,660 (12,042–16,784) | 9908 (7418–11,788) | 24,568 (20,618–27,385) | 16,617 (13,869–18,735) | 10,747 (8232–12,290) | 27,365 (23,002–30,174) | 448 (347–513) | 292 (211–342) | 740 (588–823) |
| Gallbladder and biliary tract cancer | 2383 (1983–2803) | 4543 (3731–5279) | 6926 (5941–7838) | 1985 (1673–2312) | 3853 (3161–4465) | 5839 (4973–6612) | 50 (41–59) | 98 (79–116) | 148 (124–169) |
| Pancreatic cancer | 6283 (5762–6843) | 4885 (4393–5394) | 11,168 (10,419–11,995) | 7011 (6463–7643) | 5480 (4917–6100) | 12,491 (11,601–13,400) | 179 (164–196) | 129 (116–144) | 308 (285–331) |
| Larynx cancer | 11,975 (10,284–14,128) | 2887 (2458–3493) | 14,862 (13,083–17,018) | 6477 (5676–7380) | 1612 (1345–1917) | 8090 (7222–9049) | 172 (150–199) | 46 (39–54) | 218 (193–245) |
| Tracheal, bronchial and lung cancer | 37,681 (32,768–42,292) | 11,848 (10,591–13,321) | 49,530 (44,083–54,564) | 39,180 (34,316–43,815) | 11,831 (10,442–13,380) | 51,012 (45,430–56,191) | 1013 (879–1144) | 317 (277–364) | 1330 (1171–1475) |
| Malignant skin melanoma | 3021 (2072–3909) | 2733 (2326–3212) | 5755 (4863–6883) | 617 (407–773) | 514 (452–591) | 1131 (947–1322) | 20 (14–27) | 16 (14–19) | 36 (31–44) |
| Non-melanoma skin cancer | 9359 (8443–10,285) | 4697 (4165–5264) | 14,056 (12,711–15,383) | 1015 (921–1117) | 314 (272–361) | 1330 (1223–1449) | 27 (24–30) | 9 (7–10) | 36 (33–39) |
| Breast cancer | 2058 (1810–2359) | 177,389 (148,702–207,371) | 179,447 (150,924–209,304) | 463 (408–530) | 38,117 (32,305–44,251) | 38,581 (32,795–44,698) | 14 (12–16) | 1314 (1101–1546) | 1328 (1115–1561) |
| Cervical cancer | – | 19,634 (14,721–25,505) | 19,634 (14,721–25,505) | – | 7878 (6158–9928) | 7878 (6158–9928) | – | 251 (192–323) | 251 (192–323) |
| Uterine cancer | – | 14,337 (11,576–17,621) | 14,337 (11,576–17,621) | – | 6857 (5641–8076) | 6857 (5641–8076) | – | 193 (157–228) | 193 (157–228) |
| Ovarian cancer | – | 10,946 (9024–13,395) | 10,946 (9024–13,395) | – | 6855 (5953–7833) | 6855 (5953–7833) | – | 235 (201–271) | 235 (201–271) |
| Prostate cancer | 27,533 (20,349–34,378) | – | 27,533 (20,349–34,378) | 13,861 (10,420–17,187) | – | 13,861 (10,420–17,187) | 243 (180–297) | – | 243 (180–297) |
| Testicular cancer | 3143 (2315–4266) | – | 3143 (2315–4266) | 1010 (792–1299) | – | 1010 (792–1299) | 52 (40–68) | – | 52 (40–68) |
| Kidney cancer | 5465 (4635–6345) | 2856 (2463–3279) | 8321 (7364–9305) | 3497 (3046–3942) | 1741 (1505–2039) | 5239 (4699–5834) | 110 (96–125) | 60 (52–71) | 170 (152–190) |
| Bladder cancer | 23,449 (20,144–27,360) | 6404 (5411–7716) | 29,853 (26,404–33,966) | 9452 (8524–10,545) | 3151 (2723–3587) | 12,604 (11,527–13,821) | 217 (194–244) | 73 (63–83) | 289 (263–320) |
| Brain and nervous system | 12,805 (9708–15,710) | 11,045 (9432–12,702) | 23,851 (20,099–27,075) | 10,333 (7909–12,510) | 8395 (7355–9338) | 18,729 (16,185–20,983) | 427 (321–525) | 352 (300–392) | 779 (666–881) |
| Thyroid cancer | 3654 (2966–4357) | 7536 (6026–9477) | 11,191 (9589–13,565) | 565 (484–688) | 1112 (925–1352) | 1678 (1478–2000) | 17 (14–20) | 32 (26–39) | 49 (42–58) |
| Mesothelioma | 839 (724–1015) | 260 (215–339) | 1099 (964–1313) | 794 (717–909) | 299 (245–360) | 1093 (987–1243) | 24 (22–28) | 10 (8–12) | 34 (30–39) |
| Hodgkin lymphoma | 3247 (2539–4383) | 2372 (1488–3502) | 5619 (4436–7142) | 1176 (932–1649) | 811 (547–1245) | 1987 (1655–2658) | 50 (39–70) | 36 (23–53) | 86 (70–114) |
| Non-Hodgkin lymphoma | 16,818 (14,017–20,617) | 14,549 (9501–18,687) | 31,367 (24,638–36,975) | 6745 (5684–8121) | 5999 (4194–7470) | 12,744 (10,225–14,857) | 251 (209–305) | 216 (146–274) | 466 (365–553) |
| Multiple myeloma | 2693 (2323–3268) | 2643 (2205–3157) | 5336 (4694–6150) | 2318 (2038–2761) | 2395 (2028–2834) | 4714 (4196–5411) | 66 (57–80) | 67 (56–80) | 132 (116–154) |
| Leukemia | 26,878 (23,330–31,115) | 20,800 (17,703–24,679) | 47,679 (42,513–53,365) | 14,627 (13,388–16,013) | 11,206 (10,045–12,467) | 25,833 (24,105–27,809) | 637 (579–705) | 498 (445–557) | 1135 (1053–1232) |
| Other neoplasms | 19,054 (15,995–23,621) | 17,468 (14,692–21,110) | 36,523 (32,170–42,695) | 12,292 (10,537–15,191) | 11,306 (9694–13,334) | 23,599 (20,803–27,877) | 494 (418–603) | 459 (389–546) | 953 (840–1103) |